DCM
TCRT icon

Discovery Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Discovery Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,679
Closed -$283K – 69
2023
Q4 		$283K Sell
26,679
-76,400
-74% -$920K 0.04% 48
2023
Q3 		$2.04M Sell
103,079
-1,208
-1% -$52K 0.36% 34
2023
Q2 		$7.98M Hold
104,287
– – 0.84% 36
2023
Q1 		$9.86M Sell
104,287
-3,620
-3% -$345K 1.12% 25
2022
Q4 		$10.5M Buy
107,907
+10,287
+11% +$1.49M 1.53% 21
2022
Q3 		$25.2M Buy
97,620
+3,453
+4% +$1M 3.76% 6
2022
Q2 		$17.5M Buy
94,167
+746
+0.8% +$71.3K 2.26% 14
2022
Q1 		$9.14M Buy
93,421
+4,444
+5% +$570K 0.78% 27
2021
Q4 		$14.5M Buy
88,977
+5,334
+6% +$1.17M 1.09% 22
2021
Q3 		$22.8M Buy
83,643
+395
+0.5% +$121K 1.71% 11
2021
Q2 		$33M Buy
83,248
+2,915
+4% +$1.36M 2.13% 9
2021
Q1 		$43.4M Buy
80,333
+386
+0.5% +$240K 5.81% 6
2020
Q4 		$30.2M Buy
79,947
+10,568
+15% +$4.2M 3.73% 8
2020
Q3 		$26.2M Buy
69,379
+5,094
+8% +$2.25M 4.02% 7
2020
Q2 		$31.6M Buy
64,285
+667
+1% +$297K 5.74% 5
2020
Q1 		$23.4M Buy
63,618
+32,306
+103% +$16.7M 6.43% 5
2019
Q4 		$22.2M Buy
31,312
+3,371
+12% +$2.32M 7.04% 4
2019
Q3 		$17.9M Buy
27,941
+9,598
+52% +$7.61M 3% 13
2019
Q2 		$16M Buy
18,343
+6,631
+57% +$4.56M 1.53% 22
2019
Q1 		$6.76M Buy
+11,712
New +$4.9M 0.7% 25

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Discovery Capital Management's TCRT Position: Q1 2024 in Review

Discovery Capital Management sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 26,679 shares — an estimated $283K sold.

Discovery Capital Management first reported a position in TCRT in Q1 2019 and held it in 20 quarters. The position peaked at $43.4M in Q1 2021. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Discovery Capital Management reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Discovery Capital Management sold 26,679 Alaunos Therapeutics shares in Q1 2024, an estimated $283K.
  • Discovery Capital Management first reported a position in Alaunos Therapeutics in Q1 2019 and held it in 20 quarters.
  • Discovery Capital Management's Alaunos Therapeutics position peaked at $43.4M in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Discovery Capital Management's 13F filing for Q1 2024, filed 15 May 2024.